Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

Delayed Data
As of Nov 27
 +5.96 / +10.45%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 81.00, with a high estimate of 98.00 and a low estimate of 34.00. The median estimate represents a +28.61% increase from the last price of 62.98.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 63.43%
Growthannually 13.28%


Growthquarterly 264.78%
Growthannually 55.77%
Key to the earnings and sales forecast charts.